CFB
FMS icon

Cullen/Frost Bankers’s Fresenius Medical Care FMS Stock Holding History

Cullen/Frost Bankers’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$48 – 1449
2025
Q4 		$48 Buy
+2
New +$50 ﹤0.01% 1438

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Cullen/Frost Bankers's FMS Position: Q1 2026 in Review

Cullen/Frost Bankers sold out of Fresenius Medical Care (FMS) in Q1 2026, closing a stake of 2 shares — an estimated $48 sold.

Cullen/Frost Bankers first reported a position in FMS in Q4 2025 and held it in 1 quarter. The position peaked at $48 in Q4 2025. 220 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • Cullen/Frost Bankers reported no remaining Fresenius Medical Care position as of Q1 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 2 Fresenius Medical Care shares in Q1 2026, an estimated $48.
  • Cullen/Frost Bankers first reported a position in Fresenius Medical Care in Q4 2025 and held it in 1 quarter.
  • Cullen/Frost Bankers's Fresenius Medical Care position peaked at $48 in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.